CClinicalTrials.gg
CompletedNCT00522600Updated Jul 22, 2009

Eye Drop Use in Glaucoma Patients Through Patient Surveys and Video Observations

An observational study in Glaucoma, Dry Eye Syndrome and Conjunctivitis, sponsored by Robin, Alan L., M.D.. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2009-07-22.

Sponsored by Robin, Alan L., M.D. · Observational

Study type
Observational
Time perspective
Prospective
Enrollment
200
Sex
All
01

Study summary

This study will be used to evaluate how patients put eye drops in their eyes and any problems that may arise from this activity. The information gathered will help identify common problems patients are having with putting in their eye medications. Then doctors can be better informed about the issues and provide better advice to their patients to overcome these problems.

Read the detailed description

Approximately 100 patients will take part in a one time procedure and survey as part of this project. After appropriate consent patients are asked to complete a short 2 page survey about themselves and their eye drops. Then a video recording will be made of the patient instilling eye drops in their habitual manner. The eye drops used will be sterile saline placed in either Travatan-like or Systane bottles to simulate the corresponding prescribed medication. The videos will be graded for instillation technique and combined with scoring of survey answers.

Patients will be asked to instill the drops to their left eye with their dominant hand as we expect this to be most difficult. Patients with severe (>20/200) vision loss will instill drops into their better seeing eye.

02

Conditions studied

  • Glaucoma
  • Dry Eye Syndrome
  • Conjunctivitis

Keywords

  • eyedrops
  • compliance
  • glaucoma medications
  • adherence
03

In context

Glaucoma

1,818 studies on the registry are indexed under Glaucoma; 231 are open to participants now.

This study's enrollment of 200 is above the median of 103 across 454 observational studies indexed under Glaucoma.

Browse Glaucoma studies →

Lead sponsor

Robin, Alan L., M.D. is the lead sponsor of 6 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

173 subjects enrolled and 222 video recordings were made. Ages ranged from 21-94 years old (mean:67 yrs) and subjects were 55% female and 70% caucasian.

Eligibility criteria

Inclusion Criteria:

  • Currently using topical glaucoma medications
05

Study design

Time perspective
Prospective
Enrollment
200 participants (actual)
06

Study locations

1 site
  • ALan L Robin MD PA
    Baltimore, Maryland 21209, United States
07

References and documents

Publications

  • Stone JL, Robin AL, Novack GD, Covert DW, Cagle GD. An objective evaluation of eyedrop instillation in patients with glaucoma. Arch Ophthalmol. 2009 Jun;127(6):732-6. doi: 10.1001/archophthalmol.2009.96. PubMed 19506189 ↗
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 22, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00522600
Lead sponsor
Robin, Alan L., M.D.
Collaborators
Alcon Research
First posted
Aug 30, 2007
Start date
Feb 2007
Completion
Jul 2007
Last update
Jul 22, 2009

Study contacts

Jennifer L Stone, OD
principal investigator · Alan L Robin MD PA
Alan L Robin, MD
study director · Alan L Robin MD PA

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion